Acumen Pharmaceuticals (NASDAQ: ABOS)

Acumen Pharmaceuticals

This biopharmaceutical company develops novel targeted therapies for patients with Alzheimer's disease by targeting toxic soluble amyloid beta oligomers.

Alzinova

This biopharmaceutical company develops immunotherapies and vaccines targeting toxic amyloid-beta oligomers to treat and prevent Alzheimer's disease for patients worldwide.

Aliada Therapeutics

This company develops blood-brain barrier crossing technologies and antibody therapies for patients with central nervous system diseases including Alzheimer's.

MindImmune

This pharmaceutical company develops immunomodulatory monoclonal antibodies to treat patients suffering from neurodegenerative diseases like Alzheimer's by targeting brain inflammation.

Athira Pharma

This biopharmaceutical company develops small molecule therapies for patients with neurodegenerative conditions and certain cancers.

CuraSen Therapeutics

This biopharmaceutical company develops small molecule drugs to treat patients with neurodegenerative disorders, such as Parkinson's and Alzheimer's disease.

MindImmune Therapeutics

This company develops monoclonal antibody therapeutics to treat neurodegenerative diseases and neuroinflammation for patients with central nervous system disorders.

Monument Biosciences

This biotechnology company develops disease-modifying drugs and translational biomarkers to treat Alzheimer's disease and related dementias.